---
schema_version: "secwatch.filing_event.v1"
accession: "0000078003-22-000091"
form_type: "8-K"
ticker: "PFE"
cik: "0000078003"
company_name: "PFIZER INC"
filed_at: "2022-07-28T23:59:59+00:00"
generated_at: "2026-06-24T07:48:48.646401+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Pfizer Q2 revenue $27.7B record; adj. EPS $2.04 (+92%); raises FY guidance $0.24

## Summary
- Q2 revenue $27.7B (+47% YoY, +53% operational); Paxlovid contributed $8.1B, Comirnaty +20% operationally.
- Reported diluted EPS $1.73 (+77%); adjusted diluted EPS $2.04 (+92%), beating expectations.
- Raised FY2022 adj. EPS guidance to $6.30-6.45 (lower end up $0.05); revenue reaffirmed $98-102B.
- H1 capital: $4.5B dividends, $2B share buybacks; completed $6.3B Arena acquisition; announced $13.3B Biohaven deal.

## SEC filing metadata
- accession: 0000078003-22-000091
- form_type: 8-K
- ticker: PFE
- cik: 0000078003
- company_name: PFIZER INC
- filed_at: 2022-07-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/78003/000007800322000091/0000078003-22-000091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/78003/000007800322000091/pfe-20220728.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000078003-22-000091
- JSON: https://secwatch.observer/filing/0000078003-22-000091.json
- Plain text: https://secwatch.observer/filing/0000078003-22-000091.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.